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Risk of Primary and Recurrent 
Acute Myocardial Infarction 
From Lipoprotein(a)-I 
Numerous studies in newborns, infants, children, adults, parents 
and grandparents have conclusively demonstrated that serum levels 
of lipoprotein(a) [Lp(a)] are largely genetically determined, with 
full expression of the Lp(a) gene in the first year of life. Serum 
levels of Lp(a) increase twofold between the first week and 8.5 
months of age to reach stable, life-long levels (1). Lp(a) levels at 8.5 
months of .. ge are not different from parental values and are closely 
correlated with that of the affected parent (1). Lp(a) levels in 
children 8 to 12 years old are highly correlated with premature 
coronary artery disease (CAD) and "coronary history score" in 
grandparents (2). Parents of male children with Lp(a) levels >25 
mg/dl have a 2.5-fold higher incidence of mpcardial infarction 
(MI) (3). I therefore disagree with the conclusion of Kinley et al. (4) 
from the Australian Monitoring Trends and Determinants in Car-
diovascular Disease (MONICA) study that elevated serum levels of 
Lp(a) may be the effect of advanced atherosclerosis and MI rather 
than the cause. The results from two other MONICA centers 
appear to provide insights into the paradoxically higher Lp(a) levels 
in patients without than with recurrent MI. In the Scottish 
MONICA study (5), compared with age-matched men, the fatality 
rates for MI in women were 14% higher after admission to the 
hospital and 22% higher after admission to coronary care, yet the case 
fatality rates at 28 days were identical (men 49.8%; women 49.6%). 
Women had more shock and syncope and had a worse prognosis in the 
hospital only because an equivalent number of men had died suddenly 
before reaching the hospital. Prehospital death accounted for 74% of 
deaths in men compared with only 65% in women (5). The New 
Zealand MONICA study (6) also had similar results, with identical 
28-day case fatality rates in both men and women. The higher case 
fatality rate after hospital admission was compensated by a lower 
prehospital CAD case fatality in women. A higher rate of death after 
MI in patients with high levels of Lp(a) is highly plausible, as discussed 
later. 
In a study (7) of 79 Swedish men who survived an MI before the 
age of 45, reinfarction occurred within 3 years in 16 and was fatal in 
9 (56%). Lp(a) levels were highly correlated with the coronary 
stenosis score as well as the recurrence of MI. Mean Lp(a) levels 
were twofold higher in patients without and fourfold higher in those 
with recurrent MI than in the control population. In a British study 
of 266 patients followed up for 965 days after an acute MI, elevated 
levels of Lp(a) were' an independent risk factor for cardiac mortal-
ity, with a relative risk of 2.16 on multivariant analysis (8). Those 
patients wi~h Lp(a) levels >30 mg/dl had s. significantly higher 
cardiac nvrtality rate (29.8% vs. 18.6%, P == 0.05) than those with 
Lp(a) levds <30 mg/dl. 
Patif;nts with higher levels of Lp(a) in the present study (4) 
indeed had advanced coronary atherosclerosis disease, a powerful 
prognostic factor for cardiac morbidity and mortality, including out 
of hcapital deaths (9). Others (10,11) have also reported significant 
corn~lation of Lp(a) levels with the extent, severity and rapid 
angiographic progression of CAD (12), 111 of which are highly 
predictive of the development of clinical coronary events and 
mortality after an MI (13). Thus, the exclusion of patients who died 
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outside the hospital in the study by Kinley et al. (4) may have biased 
their results and conclusions. 
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Risk of Primary and Recurrent 
Acute Myocardial Infarction 
From Lipoprotein(a)-II 
Kinlay et al. (1) have shown, as have others, that a high lipoprotein(a) 
[Lp( a)] concentration is a significant but weak predictor of myocardial 
infarction risk. In contrast, in a recent prospective cross-sectional study 
Table 1. Independent Predictors (p < 0.01) of Coronary Artery 
Disease Score in White or Indo-Asian Patients Ranked in Order of 
Explanatory Value (contribution to cumulative adjusted r2)* 
Metabolic Variable 
White patients (n = 102) 
Lp(a) 
Fasting insulin 
Total cholesterol 
Triglycerides 
Indo-Asian patients (n = 102) 
Lp(a) 
Total cholesterol 
Fasting insulin 
HOL cholesterol 
Cumulative r Value 
0.24 
0.38 
0.45 
0.50 
0.21 
0.35 
0.41 
0.45 
*Oata from Shaukat et a!. (2). HOL = high density lipoprotein; Lp(a) = 
lipoprotcln(a). 
